Allergan Overview
- Year Founded
-
1983
- Status
-
Acquired/Merged
- Employees
-
18,000
- Latest Deal Type
-
M&A
- Financing Rounds
-
13
- Investments
-
61
Allergan General Information
Description
Developer of pharmaceutical products based in Dublin, Ireland. The company offers pharmaceutical, device, biologic, surgical and regenerative medicine products, eye care, central nervous system and gastroenterology, and delivers innovative patient care, thereby enabling its customers to avail of the services for enhanced availability of medicinal products to cure several diseases in the market.
Contact Information
Website
www.allergan.comCorporate Office
- Clonshaugh Business and Technology Park
- Coolock
- Dublin D17 E400
- Ireland
Corporate Office
- Clonshaugh Business and Technology Park
- Coolock
- Dublin D17 E400
- Ireland
Allergan Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Allergan Comparisons
Industry
Financing
Details
Allergan Competitors (62)
One of Allergan’s 62 competitors is Chiesi Farmaceutici, a Private Debt Financed company based in Parma, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Chiesi Farmaceutici | Private Debt Financed | Parma, Italy | ||||
| Landsteiner Scientific | Formerly PE-Backed | Toluca, Mexico | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Elite Pharmaceuticals | Corporation | Northvale, NJ | ||||
| Mayne Pharma Group | Corporation | Salisbury, Australia |
Allergan Patents
Allergan Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260027038-A1 | Topical skin care compositions | Pending | 29-Jul-2024 | ||
| WO-2026030316-A1 | Topical skin care compositions | Pending | 29-Jul-2024 | ||
| US-20260130901-A1 | Cgrp receptor antagonist for the treatment of migraine | Pending | 11-Oct-2022 | ||
| WO-2024081718-A1 | Cgrp receptor antagonist for the treatment of migraine | Inactive | 11-Oct-2022 | ||
| US-20240066086-A1 | Topical hyperpigmentation compositions and method of use | Pending | 30-Aug-2022 | A61K36/282 |
Allergan Signals
Allergan Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Allergan Investments & Acquisitions (61)
Allergan’s most recent deal was a Accelerator/Incubator with NovoThelium. The deal was made on 04-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| NovoThelium | 04-Sep-2024 | Accelerator/Incubator | Other Devices and Supplies | ||
| Love Cork Screw | 25-Jul-2023 | Accelerator/Incubator | Beverages | ||
| Stemsontx | 15-Jul-2021 | Early Stage VC | Biotechnology | ||
| Soliton (Other Devices and Supplies) | 10-May-2021 | Merger/Acquisition | Other Devices and Supplies | ||
| Luminera | 07-Oct-2020 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Allergan Exits (5)
Allergan’s most recent exit was on 17-Nov-2016 from MedImmune (Brazikumab Global Rights). The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| MedImmune (Brazikumab Global Rights) | 17-Nov-2016 | Completed |
|
||
| Frontier Zdravlje | 27-Dec-2012 | Completed |
|
||
| Actavis Generics | 31-Oct-2012 | Completed |
|
||
| M8 Pharmaceuticals | 14-Oct-2010 | Completed |
|
||
| Anda (Distributors/Wholesale) | Merger/Acquisition | Completed |
Allergan Affiliates
Subsidiaries (7)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Medicines360 | San Francisco, CA | 2009 | |
| Keller Medical | Stuart, FL | 2008 | |
| CoolSculpting (Other Devices and Supplies) | Pleasanton, CA | 2005 | |
| Auden Mckenzie | Ruislip, United Kingdom | 1999 | |
| The Allergan Foundation | Irvine, CA | 1998 |
Allergan FAQs
-
When was Allergan founded?
Allergan was founded in 1983.
-
Where is Allergan headquartered?
Allergan is headquartered in Dublin, Ireland.
-
What is the size of Allergan?
Allergan has 18,000 total employees.
-
What industry is Allergan in?
Allergan’s primary industry is Pharmaceuticals.
-
Is Allergan a private or public company?
Allergan is a Private company.
-
What is the current valuation of Allergan?
The current valuation of Allergan is .
-
What is Allergan’s current revenue?
The current revenue for Allergan is .
-
How much funding has Allergan raised over time?
Allergan has raised $30.1B.
-
Who are Allergan’s investors?
NovaQuest Capital Management has invested in Allergan.
-
Who are Allergan’s competitors?
Chiesi Farmaceutici, Landsteiner Scientific, Novartis, Elite Pharmaceuticals, and Mayne Pharma Group are some of the 62 competitors of Allergan.
-
When was Allergan acquired?
Allergan was acquired on 08-May-2020.
-
Who acquired Allergan?
Allergan was acquired by AbbVie.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process